291 related articles for article (PubMed ID: 12366839)
1. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37.
Schmidtchen A; Frick IM; Andersson E; Tapper H; Björck L
Mol Microbiol; 2002 Oct; 46(1):157-68. PubMed ID: 12366839
[TBL] [Abstract][Full Text] [Related]
2. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin.
Schmidtchen A; Frick IM; Björck L
Mol Microbiol; 2001 Feb; 39(3):708-13. PubMed ID: 11169110
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer.
Werthén M; Davoudi M; Sonesson A; Nitsche DP; Mörgelin M; Blom K; Schmidtchen A
J Antimicrob Chemother; 2004 Oct; 54(4):772-9. PubMed ID: 15355938
[TBL] [Abstract][Full Text] [Related]
4. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.
Sieprawska-Lupa M; Mydel P; Krawczyk K; Wójcik K; Puklo M; Lupa B; Suder P; Silberring J; Reed M; Pohl J; Shafer W; McAleese F; Foster T; Travis J; Potempa J
Antimicrob Agents Chemother; 2004 Dec; 48(12):4673-9. PubMed ID: 15561843
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions.
Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M
Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L.
Andrault PM; Samsonov SA; Weber G; Coquet L; Nazmi K; Bolscher JG; Lalmanach AC; Jouenne T; Brömme D; Pisabarro MT; Lalmanach G; Lecaille F
Biochemistry; 2015 May; 54(17):2785-98. PubMed ID: 25884905
[TBL] [Abstract][Full Text] [Related]
7. Stability of the cathelicidin peptide LL-37 in a non-healing wound environment.
Grönberg A; Zettergren L; Agren MS
Acta Derm Venereol; 2011 Sep; 91(5):511-5. PubMed ID: 21547341
[TBL] [Abstract][Full Text] [Related]
8. Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa.
Strempel N; Neidig A; Nusser M; Geffers R; Vieillard J; Lesouhaitier O; Brenner-Weiss G; Overhage J
PLoS One; 2013; 8(12):e82240. PubMed ID: 24349231
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.
Ciornei CD; Sigurdardóttir T; Schmidtchen A; Bodelsson M
Antimicrob Agents Chemother; 2005 Jul; 49(7):2845-50. PubMed ID: 15980359
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence.
Thwaite JE; Hibbs S; Titball RW; Atkins TP
Antimicrob Agents Chemother; 2006 Jul; 50(7):2316-22. PubMed ID: 16801407
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous production of proteases from Brazilian clinical isolates of Pseudomonas aeruginosa.
Galdino ACM; Viganor L; Ziccardi M; Nunes APF; Dos Santos KRN; Branquinha MH; Santos ALS
Enferm Infecc Microbiol Clin; 2017 Dec; 35(10):630-637. PubMed ID: 27480954
[TBL] [Abstract][Full Text] [Related]
12. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides.
Belas R; Manos J; Suvanasuthi R
Infect Immun; 2004 Sep; 72(9):5159-67. PubMed ID: 15322010
[TBL] [Abstract][Full Text] [Related]
13. Differential Abilities of Mammalian Cathelicidins to Inhibit Bacterial Biofilm Formation and Promote Multifaceted Immune Functions of Neutrophils.
Xie F; Zan Y; Zhang X; Zhang H; Jin M; Zhang W; Zhang Y; Liu S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182913
[TBL] [Abstract][Full Text] [Related]
14. Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase.
Falciani C; Lozzi L; Scali S; Brunetti J; Bracci L; Pini A
Amino Acids; 2014 May; 46(5):1403-7. PubMed ID: 24510250
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus.
Dorschner RA; Pestonjamasp VK; Tamakuwala S; Ohtake T; Rudisill J; Nizet V; Agerberth B; Gudmundsson GH; Gallo RL
J Invest Dermatol; 2001 Jul; 117(1):91-7. PubMed ID: 11442754
[TBL] [Abstract][Full Text] [Related]
16. Highly selective end-tagged antimicrobial peptides derived from PRELP.
Malmsten M; Kasetty G; Pasupuleti M; Alenfall J; Schmidtchen A
PLoS One; 2011 Jan; 6(1):e16400. PubMed ID: 21298015
[TBL] [Abstract][Full Text] [Related]
17. The cysteine protease ApdS from
Xie F; Zan Y; Zhang Y; Zheng N; Yan Q; Zhang W; Zhang H; Jin M; Chen F; Zhang X; Liu S
J Biol Chem; 2019 Nov; 294(47):17962-17977. PubMed ID: 31619521
[No Abstract] [Full Text] [Related]
18. Pseudomonas aeruginosa elastase degrades surfactant proteins A and D.
Mariencheck WI; Alcorn JF; Palmer SM; Wright JR
Am J Respir Cell Mol Biol; 2003 Apr; 28(4):528-37. PubMed ID: 12654643
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids.
Barańska-Rybak W; Sonesson A; Nowicki R; Schmidtchen A
J Antimicrob Chemother; 2006 Feb; 57(2):260-5. PubMed ID: 16387752
[TBL] [Abstract][Full Text] [Related]
20. Domain 5 of high molecular weight kininogen is antibacterial.
Nordahl EA; Rydengård V; Mörgelin M; Schmidtchen A
J Biol Chem; 2005 Oct; 280(41):34832-9. PubMed ID: 16091369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
